Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001231919-25-000676
Filing Date
2025-12-30
Accepted
2025-12-30 16:22:27
Documents
1
Effectiveness Date
2025-12-30
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 14261
  Complete submission text file 0001231919-25-000676.txt   15638
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

EIN.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-568472 | Film No.: 251614544
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)